pigeons of both sexes, weighing between 400 and 600 g. The birds were divided into two groups of ten each group being used on alternate wk ensuring a rest period of two wk between injections. All drugs were injected intravenously into the brachial vein over a period of 10 to 15 sec.
All drug injections were randomized, using a latin square, and the pigeons used were chosen in random fashion from within the same groups. To ensure that the pigeons had a full crop before drug injection, both food and water were withdrawn the night before the experiments and access to these was restored 5 to 6 hr before the pigeons were to be used.
To guard against the possibility of conditioning observed by Leib and Mulinos (24, 25) control injections of saline were given from time to time. In twenty-five such tests, no emesis was observed after injection of saline. Eight experiments at each dose-level of protoveratrine A and B were performed. With the protoverine acetates fewer experiments with each dose were performed as the amount of alkaloids at our disposal was minimal. Behaviour of birds was accurately noted upto 60 min after injection. The ED,, values were calculated according to the method of Litchfield and Wilcoxon (26) . RESULTS 
1) Protoveratrine A and pr•otoveratrine B.
In appropriate doses, these agents produced a retching movement followed by emesis. Immediately after injection the pigeons either withdrew to one corner of the cage or sat down, depending upon the magnitude of the dose. There was blinking of the eyes, shiver ing and unsteady gait. Emesis, if occurring, followed within 2 to 5 min. Table 1 shows the doses used, the average latent period for emesis to occur, the relationship between dose and number of birds vomiting, and the average of vomiting bouts seen after a single ef Responses plotted on log-probability paper, according to the method of Li tchfield and Wilcoxon (26) . For further details, see text. fective injection per pigeon. Fig. 1 plots graphically the dose-response curves for the two drugs. Table 2 shows the ED,,, slope ratio and potency ratio for the two drugs, with 19/20 confidence limits. Protoveratrine A was significantly more active than protoveratrine B and for confidence limits of 19/20, the relative potency was between 1.81 and 2.92 times that of protoveratrine B. The slope ratio of the two curves was 1.03 and deviation from parallelism was insignifi cant.
2) Protoherine acetates A total of 39 experiments were carried out with these esters.
No emesis was observed even with doses as high as 6 mg/kg. Flapping of the wings, unsteady gait, blinking of the
eyes, shivering, opening of the beak and withdrawal to one corner of the cage were com monly seen after injection of an appropriate dose of PPA, PIPA, PTA or PHA. PADA and PATA were less active than the other acetates; nevertheless, retching movements and blinking of the eyes were a constant feature. Increased salivation was observed with PATA, PTA, PPA and PIPA. Table 3 shows in tabular form the effects observed with each drug at different doses.
DISCUSSION
Comparative studies of intravenously administered protoveratrine A and protoveratrine B in experimental animals and human beings have indicated that both alkaloids have quali tatively similar hypotensive, bradycrotic and emetic activity.
In the experiments reported in this study, a quantitative difference is clearly evident between protoveratrine A and protoveratrine B with regard to emetic activity in pigeons, when the drugs were given intravenous]y. In Winer's study (20) (27) , using the intravenous route, found no significant difference between protoveratrine A and protoveratrine B in dogs. Species differences are known to play a very important part in the emetic response to drugs (28-31), and it is quite possible that this disparity is due to a species difference. All acetic acid esters of protoverine were devoid of emetic activity in doses upto 6 mg/kg, however, a few side-effects were observed in the birds approx 3 to 5 min after injection of the drug (see Table 3 ). These effects were more marked with PTA, PPA, PIPA and PHA as compared to PADA and PATA. Frequency of these effects increased with an increase in dosage. Retching movements were a common feature associated with administration of all alkaloids. Tanaka (32) reported similar effects in mice with naturally occurring esters of protoverine, germine and veracevine. He also observed that the mice appeared depressed and locomotor activity was reduced; such changes being ascribed to the accompa nying cardiorespiratory disturbance. A reduced initiative to move, sitting or standing in one corner of the cage were also seen with PTA, PPA, PIPA and PHA in the experiments reported in this study. The veratrum alkaloids have been observed to stimulate peripheral sensory structures, and hiccups, tightness in the epigastrium and chest, parasthesias in the mouth, throat, chest, extremities and genitalia have been known to occur in patients under going treatment with these alkaloids (19, 20) . Because of the difficulty in assessing subjec tive phenomenon in experimental animals it is not known whether the above factors con tributed to the reduced initiative to move in the experiments reported herein. With higher doses other unusual features observed were opening of the beak, flapping of the wings, blinking, unsteady gait, inability to fly, shivering and increased salivation.
On the basis of the experiments reported herein, it was not possible to elicit emesis in pigeons using the semi-synthetic protoverine acetates in doses upto 6 mg/kg.
On On the other hand six semi-synthetic acetic acid esters of protoverine: protoverine acetonide diacetate, protoverine triacetate; protoverine acetonide triacetate; protoverine pentaacetate, protoverine isopentaacetate and protoverine hexaacetate were devoid of emetic activity in doses upto 6 mg/kg. Some of these alkaloids have earlier been shown by us to increase tension development in the skeletal muscles without producing the hypotension which is normally associated with the use of the veratrum alkaloids such an effect has profitably been employed recently, in the treatment of myasthenic individuals who received germine diacetate. 
